WallStreetZenWallStreetZen

NASDAQ: SGMT
Sagimet Biosciences Inc Stock Ownership - Who owns Sagimet Biosciences?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Sagimet Biosciences Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
David HappelPresident CEO2024-03-2612,100$5.27
$63.73kBuy
David HappelPresident CEO2023-12-071,600$4.10
$6.56kBuy
David HappelPresident CEO2023-11-16590$2.35
$1.39kBuy
George KembleExecutive Chairman2023-09-075,630$0.79
$4.45kBuy
Beth C. SeidenbergDirector2023-07-1846,875$16.00
$750.00kBuy
New Enterprise Associates 13 LP10% Owner2023-07-1830,000$16.00
$480.00kBuy
New Enterprise Associates 13 LP10% Owner2023-07-18662$16.00
$10.59kSell
New Enterprise Associates 13 LP10% Owner2023-07-1813,404$0.80
$10.66kBuy

1 of 1

SGMT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SGMT insiders and whales buy or sell their stock.

SGMT Shareholders

What type of owners hold Sagimet Biosciences Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Nea Management Company LLC12.06%3,850,275$15.09MInstitution
Patrick J. Kerins9.44%3,013,414$11.81MInsider
Forest Baskett9.44%3,011,575$11.81MInsider
Scott D. Sandell9.42%3,007,272$11.79MInsider
Nea Partners 13 Limited Partnership9.40%3,000,275$11.76MInsider
New Enterprise Associates 13 LP9.40%3,000,275$11.76MInsider
Beth C. Seidenberg6.36%2,031,118$7.96MInsider
Fmr LLC6.02%1,922,056$7.53MInstitution
Kpcb Pbd Associates LLC5.95%1,899,475$7.45MInsider
Jinzi Jason Wu5.18%1,654,701$6.49MInsider

1 of 3

SGMT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SGMT39.98%60.02%Net BuyingNet Buying
VTGN38.92%61.08%Net Buying
LENZ49.99%50.01%Net BuyingNet Buying
DBVT39.10%15.37%Net BuyingNet Buying
MOLN2.91%0.00%
View Top Biotech Stocks

Sagimet Biosciences Stock Ownership FAQ

Who owns Sagimet Biosciences?

Sagimet Biosciences (NASDAQ: SGMT) is owned by 45.26% institutional shareholders, 67.96% Sagimet Biosciences insiders, and 0.00% retail investors. Patrick J. Kerins is the largest individual Sagimet Biosciences shareholder, owning 3.01M shares representing 9.44% of the company. Patrick J. Kerins's Sagimet Biosciences shares are currently valued at $12.23M.

If you're new to stock investing, here's how to buy Sagimet Biosciences stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.